 |
Articles: Neuro/Psych Pharmacol |
Prior Articles
Review: differences in efficacy and acceptability exist for 12 new-generation antidepressants for major depression
Evidence-Based Medicine, 10/26/09
Evidence Based Medicine
Revew Article
Open-label study of high (30 mg) and moderate (20 mg) dose escitalopram for the treatment of obsessive-compulsive disorder
International Clinical Psychopharmacology, 10/23/09 Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Drug and Alcohol Dependence, 10/23/09 A Genomewide Association Study of Citalopram Response in Major Depressive Disorder
Biological Psychiatry, 10/23/09 Asenapine versus olanzapine in acute mania: a double-blind extension study
Bipolar Disorders, 10/22/09 Risperidone dose for schizophrenia
Cochrane Reviews, 10/22/09
Revew Article
Omega-3 Augmentation of Sertraline in Treatment of Depression in Patients With Coronary Heart Disease: A Randomized Controlled Trial
JAMA, 10/22/09 Stress hormones mediate drug resistance to paclitaxel in human breast cancer cells through a CDK-1-dependent pathway
Psychoneuroendocrinology, 10/22/09 Olanzapine in the long-term treatment of bipolar disorder: A systematic review and meta-analysis
Journal of Psychopharmacology, 10/21/09 Glucose Tolerance in Depressed Inpatients, under Treatment with Mirtazapine and in Healthy Controls
Experimental and Clinical Endocrinology & Diabetes, 10/21/09 Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism
Journal of Psychopharmacology, 10/20/09 Estimation of clonazepam abuse liability: a new method using a reimbursed drug database
International Clinical Psychopharmacology, 10/20/09 Treating attention-deficit/hyperactivity disorder beyond symptom control alone in children and adolescents: a review of the potential benefits of long-acting stimulants
European Child and Adolescent Psychiatry, 10/20/09 Aripiprazole versus other atypical antipsychotics for schizophrenia
Cochrane Reviews, 10/20/09
Revew Article
A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia
Journal of Psychopharmacology, 10/19/09 Diabetes and Poor Disease Control: Is Comorbid Depression Associated With Poor Medication Adherence or Lack of Treatment Intensification
Psychosomatic Medicine, 10/19/09 How High-Resolution Basal-State Functional Imaging Can Guide the Development of New Pharmacotherapies for Schizophrenia
Schizophrenia Bulletin, 10/19/09 Multivariate therapeutic approach to binge-eating disorder: combined nutritional, psychological and pharmacological treatment
International Clinical Psychopharmacology, 10/16/09 Serotonin function in pathological gambling: blunted growth hormone response to Sumatriptan
Journal of Psychopharmacology, 10/16/09 What Makes Patients with Fibromyalgia Feel Better? Correlations Between Patient Global Impression of Improvement and Changes in Clinical Symptoms and Function: A Pooled Analysis of 4 Randomized Placebo-controlled Trials of Duloxetine
Journal of Rheumatology, 10/16/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addiction
more...
|
250 Available Pages
|
|
